Virtual Walking and Neuromulation to Reduce Neuropathic Pain After a Spinal Cord Injury

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre for Interdisciplinary Research in Rehabilitation of Greater Montreal

About this trial

The goal of this single-subject design is to evaluate an intervention combining neuromodulation, virtual reality, and muscle vibration to reduce neuropathic pain in individuals following a spinal cord injury.

The investigators aim to quantify the effects of the intervention on the intensity and characteristics of neuropathic pain, as well as its impact on daily functioning in individuals undergoing SCI rehabilitation. Additionally, the investigators seek to gain a better understanding of participants' experiences with the intervention by exploring effects not captured by standardized questionnaires, and by examining the role and meaning of the intervention in their management and experience of pain.

Finally, the investigators aim to assess the feasibility and clinical relevance of implementing this intervention in a rehabilitation setting.

All participants living with neuropathic pain following a spinal cord injury will take part in ten intervention sessions. They will also be invited to complete standardized questionnaires and participate in a semi-structured interview. In addition, their clinicians will be invited to participate in a focus group.

Eligibility criteria

Qualifiers

over 18 years old

a score of ≥ 4/10 on the Douleur Neuropathique en 4 Questions (DN4)

classified AIS A to D

neuropathic pain with an intensity of ≥ 4/10 on the simple numerical rating scale (This threshold is often chosen to better observe a potential analgesic effect)

Disqualifiers

pregnancy,

epilepsy,

cancer,

pacemaker,

Trial design

Treatments tested in this trial

  • Transcranial Direct Current Stimulation (tDCS) combined with virtual reality and muscle vibration

Treatment groups

10 Participants
are divided into 1 treatment group

Locations

This trial has no locations